𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cellular binding partners of the human papillomavirus E6 protein

✍ Scribed by Sandy S. Tungteakkhun; Penelope J. Duerksen-Hughes

Publisher
Springer Vienna
Year
2008
Tongue
English
Weight
354 KB
Volume
153
Category
Article
ISSN
1432-8798

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Involvement of a cellular ubiquitin-prot
Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6
✍ Yoko Matsumoto; Shunsuke Nakagawa; Tetsu Yano; Shin Takizawa; Kazunori Nagasaka; πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 273 KB

Human scribble (hScrib), which was identified as substrate of human papillomavirus (HPV) E6 for ubiquitin-mediated degradation dependent on ubiquitin-protein ligase E6AP, is a human homolog of Drosophila neoplastic tumor suppressor scribble, in which mutation causes loss of polarity and overgrowth o

Human papillomavirus-16 E7 protein inhib
Human papillomavirus-16 E7 protein inhibits the DNA interaction of the TATA binding transcription factor
✍ Edio Maldonado; MarΓ­a Eugenia Cabrejos; Lawrence Banks; Jorge E. Allende πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 165 KB

## Abstract Previous studies have shown that the HPV‐16 E7 protein interacts with TBP. This interaction was found to take place through residues in the carboxy terminal half of E7, mutation of which resulted in weaker transforming activity. In addition, binding of E7 to TBP was found to be increase

Targetting of the N-terminal domain of t
Targetting of the N-terminal domain of the human papillomavirus type 16 E6 oncoprotein with monomeric scFvs blocks the E6-mediated degradation of cellular p53
✍ Christine Giovane; Gilles TravΓ©; AmΓ©lie Briones; Yves Lutz; Bohdan Wasylyk; Etie πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 443 KB πŸ‘ 1 views

The E6 protein of cancer-associated human papillomavirus type 16 (HPV16) binds to cellular p53 and promotes its degradation through the ubiquitin pathway. In an attempt to identify the regions of E6 that could be targetted for functional inhibition, we generated monoclonal antibodies to the HPV16 E6